[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Inactivated Vaccine Sales Market Report 2017

December 2017 | 100 pages | ID: GD444606F07EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Inactivated Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Inactivated Vaccine for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Inactivated Vaccine market competition by top manufacturers/players, with Inactivated Vaccine sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Astellas Pharma (Japan)
  • CSL Limited (Australia)
  • Emergent BioSolutions (U.S.)
  • GlaxoSmithKline (U.K.)
  • Johnson & Johnson (U.S.)
  • MedImmune (U.S.)
  • Merck & Co (U.S.)
  • Pfizer (U.S.)
  • Sanofi Pasteur (France)
  • Serum Institute of India Pvt (India)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • By End User
    • Pediatrics
    • Adults
  • By Disease Indication
    • Pneumococcal
    • Influenza
    • HPV
    • Hepatitis
    • Rotavirus
    • DTP
    • Polio
    • MMR
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Medical Center
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Inactivated Vaccine Sales Market Report 2017

1 INACTIVATED VACCINE MARKET OVERVIEW

1.1 Product Overview and Scope of Inactivated Vaccine
1.2 Classification of Inactivated Vaccine by Product Category
  1.2.1 Global Inactivated Vaccine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Inactivated Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Pediatrics
  1.2.4 Adults
1.3 Global Inactivated Vaccine Market by Application/End Users
  1.3.1 Global Inactivated Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Medical Center
  1.3.4 Others
1.4 Global Inactivated Vaccine Market by Region
  1.4.1 Global Inactivated Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Inactivated Vaccine Status and Prospect (2012-2022)
  1.4.3 China Inactivated Vaccine Status and Prospect (2012-2022)
  1.4.4 Europe Inactivated Vaccine Status and Prospect (2012-2022)
  1.4.5 Japan Inactivated Vaccine Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Inactivated Vaccine Status and Prospect (2012-2022)
  1.4.7 India Inactivated Vaccine Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Inactivated Vaccine (2012-2022)
  1.5.1 Global Inactivated Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 Global Inactivated Vaccine Revenue and Growth Rate (2012-2022)

2 GLOBAL INACTIVATED VACCINE COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Inactivated Vaccine Market Competition by Players/Suppliers
  2.1.1 Global Inactivated Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Inactivated Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Inactivated Vaccine (Volume and Value) by Type
  2.2.1 Global Inactivated Vaccine Sales and Market Share by Type (2012-2017)
  2.2.2 Global Inactivated Vaccine Revenue and Market Share by Type (2012-2017)
2.3 Global Inactivated Vaccine (Volume and Value) by Region
  2.3.1 Global Inactivated Vaccine Sales and Market Share by Region (2012-2017)
  2.3.2 Global Inactivated Vaccine Revenue and Market Share by Region (2012-2017)
2.4 Global Inactivated Vaccine (Volume) by Application

3 UNITED STATES INACTIVATED VACCINE (VOLUME, VALUE AND SALES PRICE)

3.1 United States Inactivated Vaccine Sales and Value (2012-2017)
  3.1.1 United States Inactivated Vaccine Sales and Growth Rate (2012-2017)
  3.1.2 United States Inactivated Vaccine Revenue and Growth Rate (2012-2017)
  3.1.3 United States Inactivated Vaccine Sales Price Trend (2012-2017)
3.2 United States Inactivated Vaccine Sales Volume and Market Share by Players
3.3 United States Inactivated Vaccine Sales Volume and Market Share by Type
3.4 United States Inactivated Vaccine Sales Volume and Market Share by Application

4 CHINA INACTIVATED VACCINE (VOLUME, VALUE AND SALES PRICE)

4.1 China Inactivated Vaccine Sales and Value (2012-2017)
  4.1.1 China Inactivated Vaccine Sales and Growth Rate (2012-2017)
  4.1.2 China Inactivated Vaccine Revenue and Growth Rate (2012-2017)
  4.1.3 China Inactivated Vaccine Sales Price Trend (2012-2017)
4.2 China Inactivated Vaccine Sales Volume and Market Share by Players
4.3 China Inactivated Vaccine Sales Volume and Market Share by Type
4.4 China Inactivated Vaccine Sales Volume and Market Share by Application

5 EUROPE INACTIVATED VACCINE (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Inactivated Vaccine Sales and Value (2012-2017)
  5.1.1 Europe Inactivated Vaccine Sales and Growth Rate (2012-2017)
  5.1.2 Europe Inactivated Vaccine Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Inactivated Vaccine Sales Price Trend (2012-2017)
5.2 Europe Inactivated Vaccine Sales Volume and Market Share by Players
5.3 Europe Inactivated Vaccine Sales Volume and Market Share by Type
5.4 Europe Inactivated Vaccine Sales Volume and Market Share by Application

6 JAPAN INACTIVATED VACCINE (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Inactivated Vaccine Sales and Value (2012-2017)
  6.1.1 Japan Inactivated Vaccine Sales and Growth Rate (2012-2017)
  6.1.2 Japan Inactivated Vaccine Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Inactivated Vaccine Sales Price Trend (2012-2017)
6.2 Japan Inactivated Vaccine Sales Volume and Market Share by Players
6.3 Japan Inactivated Vaccine Sales Volume and Market Share by Type
6.4 Japan Inactivated Vaccine Sales Volume and Market Share by Application

7 SOUTHEAST ASIA INACTIVATED VACCINE (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Inactivated Vaccine Sales and Value (2012-2017)
  7.1.1 Southeast Asia Inactivated Vaccine Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Inactivated Vaccine Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Inactivated Vaccine Sales Price Trend (2012-2017)
7.2 Southeast Asia Inactivated Vaccine Sales Volume and Market Share by Players
7.3 Southeast Asia Inactivated Vaccine Sales Volume and Market Share by Type
7.4 Southeast Asia Inactivated Vaccine Sales Volume and Market Share by Application

8 INDIA INACTIVATED VACCINE (VOLUME, VALUE AND SALES PRICE)

8.1 India Inactivated Vaccine Sales and Value (2012-2017)
  8.1.1 India Inactivated Vaccine Sales and Growth Rate (2012-2017)
  8.1.2 India Inactivated Vaccine Revenue and Growth Rate (2012-2017)
  8.1.3 India Inactivated Vaccine Sales Price Trend (2012-2017)
8.2 India Inactivated Vaccine Sales Volume and Market Share by Players
8.3 India Inactivated Vaccine Sales Volume and Market Share by Type
8.4 India Inactivated Vaccine Sales Volume and Market Share by Application

9 GLOBAL INACTIVATED VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Astellas Pharma (Japan)
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Inactivated Vaccine Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Astellas Pharma (Japan) Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 CSL Limited (Australia)
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Inactivated Vaccine Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 CSL Limited (Australia) Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Emergent BioSolutions (U.S.)
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Inactivated Vaccine Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Emergent BioSolutions (U.S.) Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline (U.K.)
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Inactivated Vaccine Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 GlaxoSmithKline (U.K.) Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Johnson & Johnson (U.S.)
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Inactivated Vaccine Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Johnson & Johnson (U.S.) Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 MedImmune (U.S.)
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Inactivated Vaccine Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 MedImmune (U.S.) Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Merck & Co (U.S.)
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Inactivated Vaccine Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Merck & Co (U.S.) Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Pfizer (U.S.)
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Inactivated Vaccine Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Pfizer (U.S.) Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Sanofi Pasteur (France)
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Inactivated Vaccine Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Sanofi Pasteur (France) Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Serum Institute of India Pvt (India)
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Inactivated Vaccine Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Serum Institute of India Pvt (India) Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview

10 INACTIVATED VACCINE MAUFACTURING COST ANALYSIS

10.1 Inactivated Vaccine Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Inactivated Vaccine
10.3 Manufacturing Process Analysis of Inactivated Vaccine

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Inactivated Vaccine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Inactivated Vaccine Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL INACTIVATED VACCINE MARKET FORECAST (2017-2022)

14.1 Global Inactivated Vaccine Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Inactivated Vaccine Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Inactivated Vaccine Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Inactivated Vaccine Price and Trend Forecast (2017-2022)
14.2 Global Inactivated Vaccine Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Inactivated Vaccine Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Inactivated Vaccine Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Inactivated Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Inactivated Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Inactivated Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Inactivated Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Inactivated Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Inactivated Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Inactivated Vaccine Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Inactivated Vaccine Sales Forecast by Type (2017-2022)
  14.3.2 Global Inactivated Vaccine Revenue Forecast by Type (2017-2022)
  14.3.3 Global Inactivated Vaccine Price Forecast by Type (2017-2022)
14.4 Global Inactivated Vaccine Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Inactivated Vaccine
Figure Global Inactivated Vaccine Sales Volume Comparison (K MT) by Type (2012-2022)
Figure Global Inactivated Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Pediatrics Product Picture
Figure Adults Product Picture
Figure Global Inactivated Vaccine Sales Comparison (K MT) by Application (2012-2022)
Figure Global Sales Market Share of Inactivated Vaccine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Inactivated Vaccine Market Size (Million USD) by Regions (2012-2022)
Figure United States Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Inactivated Vaccine Sales Volume (K MT) and Growth Rate (2012-2022)
Figure Global Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Inactivated Vaccine Sales Volume (K MT) (2012-2017)
Table Global Inactivated Vaccine Sales (K MT) of Key Players/Suppliers (2012-2017)
Table Global Inactivated Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Inactivated Vaccine Sales Share by Players/Suppliers
Figure 2017 Inactivated Vaccine Sales Share by Players/Suppliers
Figure Global Inactivated Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Inactivated Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Inactivated Vaccine Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Inactivated Vaccine Revenue Share by Players
Table 2017 Global Inactivated Vaccine Revenue Share by Players
Table Global Inactivated Vaccine Sales (K MT) and Market Share by Type (2012-2017)
Table Global Inactivated Vaccine Sales Share (K MT) by Type (2012-2017)
Figure Sales Market Share of Inactivated Vaccine by Type (2012-2017)
Figure Global Inactivated Vaccine Sales Growth Rate by Type (2012-2017)
Table Global Inactivated Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Inactivated Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Inactivated Vaccine by Type (2012-2017)
Figure Global Inactivated Vaccine Revenue Growth Rate by Type (2012-2017)
Table Global Inactivated Vaccine Sales Volume (K MT) and Market Share by Region (2012-2017)
Table Global Inactivated Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Inactivated Vaccine by Region (2012-2017)
Figure Global Inactivated Vaccine Sales Growth Rate by Region in 2016
Table Global Inactivated Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Inactivated Vaccine Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Inactivated Vaccine by Region (2012-2017)
Figure Global Inactivated Vaccine Revenue Growth Rate by Region in 2016
Table Global Inactivated Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Inactivated Vaccine Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Inactivated Vaccine by Region (2012-2017)
Figure Global Inactivated Vaccine Revenue Market Share by Region in 2016
Table Global Inactivated Vaccine Sales Volume (K MT) and Market Share by Application (2012-2017)
Table Global Inactivated Vaccine Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Inactivated Vaccine by Application (2012-2017)
Figure Global Inactivated Vaccine Sales Market Share by Application (2012-2017)
Figure United States Inactivated Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure United States Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Inactivated Vaccine Sales Price (USD/MT) Trend (2012-2017)
Table United States Inactivated Vaccine Sales Volume (K MT) by Players (2012-2017)
Table United States Inactivated Vaccine Sales Volume Market Share by Players (2012-2017)
Figure United States Inactivated Vaccine Sales Volume Market Share by Players in 2016
Table United States Inactivated Vaccine Sales Volume (K MT) by Type (2012-2017)
Table United States Inactivated Vaccine Sales Volume Market Share by Type (2012-2017)
Figure United States Inactivated Vaccine Sales Volume Market Share by Type in 2016
Table United States Inactivated Vaccine Sales Volume (K MT) by Application (2012-2017)
Table United States Inactivated Vaccine Sales Volume Market Share by Application (2012-2017)
Figure United States Inactivated Vaccine Sales Volume Market Share by Application in 2016
Figure China Inactivated Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure China Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Inactivated Vaccine Sales Price (USD/MT) Trend (2012-2017)
Table China Inactivated Vaccine Sales Volume (K MT) by Players (2012-2017)
Table China Inactivated Vaccine Sales Volume Market Share by Players (2012-2017)
Figure China Inactivated Vaccine Sales Volume Market Share by Players in 2016
Table China Inactivated Vaccine Sales Volume (K MT) by Type (2012-2017)
Table China Inactivated Vaccine Sales Volume Market Share by Type (2012-2017)
Figure China Inactivated Vaccine Sales Volume Market Share by Type in 2016
Table China Inactivated Vaccine Sales Volume (K MT) by Application (2012-2017)
Table China Inactivated Vaccine Sales Volume Market Share by Application (2012-2017)
Figure China Inactivated Vaccine Sales Volume Market Share by Application in 2016
Figure Europe Inactivated Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Inactivated Vaccine Sales Price (USD/MT) Trend (2012-2017)
Table Europe Inactivated Vaccine Sales Volume (K MT) by Players (2012-2017)
Table Europe Inactivated Vaccine Sales Volume Market Share by Players (2012-2017)
Figure Europe Inactivated Vaccine Sales Volume Market Share by Players in 2016
Table Europe Inactivated Vaccine Sales Volume (K MT) by Type (2012-2017)
Table Europe Inactivated Vaccine Sales Volume Market Share by Type (2012-2017)
Figure Europe Inactivated Vaccine Sales Volume Market Share by Type in 2016
Table Europe Inactivated Vaccine Sales Volume (K MT) by Application (2012-2017)
Table Europe Inactivated Vaccine Sales Volume Market Share by Application (2012-2017)
Figure Europe Inactivated Vaccine Sales Volume Market Share by Application in 2016
Figure Japan Inactivated Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Japan Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Inactivated Vaccine Sales Price (USD/MT) Trend (2012-2017)
Table Japan Inactivated Vaccine Sales Volume (K MT) by Players (2012-2017)
Table Japan Inactivated Vaccine Sales Volume Market Share by Players (2012-2017)
Figure Japan Inactivated Vaccine Sales Volume Market Share by Players in 2016
Table Japan Inactivated Vaccine Sales Volume (K MT) by Type (2012-2017)
Table Japan Inactivated Vaccine Sales Volume Market Share by Type (2012-2017)
Figure Japan Inactivated Vaccine Sales Volume Market Share by Type in 2016
Table Japan Inactivated Vaccine Sales Volume (K MT) by Application (2012-2017)
Table Japan Inactivated Vaccine Sales Volume Market Share by Application (2012-2017)
Figure Japan Inactivated Vaccine Sales Volume Market Share by Application in 2016
Figure Southeast Asia Inactivated Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Southeast Asia Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Inactivated Vaccine Sales Price (USD/MT) Trend (2012-2017)
Table Southeast Asia Inactivated Vaccine Sales Volume (K MT) by Players (2012-2017)
Table Southeast Asia Inactivated Vaccine Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Inactivated Vaccine Sales Volume Market Share by Players in 2016
Table Southeast Asia Inactivated Vaccine Sales Volume (K MT) by Type (2012-2017)
Table Southeast Asia Inactivated Vaccine Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Inactivated Vaccine Sales Volume Market Share by Type in 2016
Table Southeast Asia Inactivated Vaccine Sales Volume (K MT) by Application (2012-2017)
Table Southeast Asia Inactivated Vaccine Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Inactivated Vaccine Sales Volume Market Share by Application in 2016
Figure India Inactivated Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure India Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Inactivated Vaccine Sales Price (USD/MT) Trend (2012-2017)
Table India Inactivated Vaccine Sales Volume (K MT) by Players (2012-2017)
Table India Inactivated Vaccine Sales Volume Market Share by Players (2012-2017)
Figure India Inactivated Vaccine Sales Volume Market Share by Players in 2016
Table India Inactivated Vaccine Sales Volume (K MT) by Type (2012-2017)
Table India Inactivated Vaccine Sales Volume Market Share by Type (2012-2017)
Figure India Inactivated Vaccine Sales Volume Market Share by Type in 2016
Table India Inactivated Vaccine Sales Volume (K MT) by Application (2012-2017)
Table India Inactivated Vaccine Sales Volume Market Share by Application (2012-2017)
Figure India Inactivated Vaccine Sales Volume Market Share by Application in 2016
Table Astellas Pharma (Japan) Basic Information List
Table Astellas Pharma (Japan) Inactivated Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Astellas Pharma (Japan) Inactivated Vaccine Sales Growth Rate (2012-2017)
Figure Astellas Pharma (Japan) Inactivated Vaccine Sales Global Market Share (2012-2017
Figure Astellas Pharma (Japan) Inactivated Vaccine Revenue Global Market Share (2012-2017)
Table CSL Limited (Australia) Basic Information List
Table CSL Limited (Australia) Inactivated Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure CSL Limited (Australia) Inactivated Vaccine Sales Growth Rate (2012-2017)
Figure CSL Limited (Australia) Inactivated Vaccine Sales Global Market Share (2012-2017
Figure CSL Limited (Australia) Inactivated Vaccine Revenue Global Market Share (2012-2017)
Table Emergent BioSolutions (U.S.) Basic Information List
Table Emergent BioSolutions (U.S.) Inactivated Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Emergent BioSolutions (U.S.) Inactivated Vaccine Sales Growth Rate (2012-2017)
Figure Emergent BioSolutions (U.S.) Inactivated Vaccine Sales Global Market Share (2012-2017
Figure Emergent BioSolutions (U.S.) Inactivated Vaccine Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline (U.K.) Basic Information List
Table GlaxoSmithKline (U.K.) Inactivated Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline (U.K.) Inactivated Vaccine Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline (U.K.) Inactivated Vaccine Sales Global Market Share (2012-2017
Figure GlaxoSmithKline (U.K.) Inactivated Vaccine Revenue Global Market Share (2012-2017)
Table Johnson & Johnson (U.S.) Basic Information List
Table Johnson & Johnson (U.S.) Inactivated Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson (U.S.) Inactivated Vaccine Sales Growth Rate (2012-2017)
Figure Johnson & Johnson (U.S.) Inactivated Vaccine Sales Global Market Share (2012-2017
Figure Johnson & Johnson (U.S.) Inactivated Vaccine Revenue Global Market Share (2012-2017)
Table MedImmune (U.S.) Basic Information List
Table MedImmune (U.S.) Inactivated Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure MedImmune (U.S.) Inactivated Vaccine Sales Growth Rate (2012-2017)
Figure MedImmune (U.S.) Inactivated Vaccine Sales Global Market Share (2012-2017
Figure MedImmune (U.S.) Inactivated Vaccine Revenue Global Market Share (2012-2017)
Table Merck & Co (U.S.) Basic Information List
Table Merck & Co (U.S.) Inactivated Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck & Co (U.S.) Inactivated Vaccine Sales Growth Rate (2012-2017)
Figure Merck & Co (U.S.) Inactivated Vaccine Sales Global Market Share (2012-2017
Figure Merck & Co (U.S.) Inactivated Vaccine Revenue Global Market Share (2012-2017)
Table Pfizer (U.S.) Basic Information List
Table Pfizer (U.S.) Inactivated Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer (U.S.) Inactivated Vaccine Sales Growth Rate (2012-2017)
Figure Pfizer (U.S.) Inactivated Vaccine Sales Global Market Share (2012-2017
Figure Pfizer (U.S.) Inactivated Vaccine Revenue Global Market Share (2012-2017)
Table Sanofi Pasteur (France) Basic Information List
Table Sanofi Pasteur (France) Inactivated Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Pasteur (France) Inactivated Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi Pasteur (France) Inactivated Vaccine Sales Global Market Share (2012-2017
Figure Sanofi Pasteur (France) Inactivated Vaccine Revenue Global Market Share (2012-2017)
Table Serum Institute of India Pvt (India) Basic Information List
Table Serum Institute of India Pvt (India) Inactivated Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Serum Institute of India Pvt (India) Inactivated Vaccine Sales Growth Rate (2012-2017)
Figure Serum Institute of India Pvt (India) Inactivated Vaccine Sales Global Market Share (2012-2017
Figure Serum Institute of India Pvt (India) Inactivated Vaccine Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Inactivated Vaccine
Figure Manufacturing Process Analysis of Inactivated Vaccine
Figure Inactivated Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Inactivated Vaccine Major Players in 2016
Table Major Buyers of Inactivated Vaccine
Table Distributors/Traders List
Figure Global Inactivated Vaccine Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Global Inactivated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Inactivated Vaccine Price (USD/MT) and Trend Forecast (2017-2022)
Table Global Inactivated Vaccine Sales Volume (K MT) Forecast by Regions (2017-2022)
Figure Global Inactivated Vaccine Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Inactivated Vaccine Sales Volume Market Share Forecast by Regions in 2022
Table Global Inactivated Vaccine Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Inactivated Vaccine Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Inactivated Vaccine Revenue Market Share Forecast by Regions in 2022
Figure United States Inactivated Vaccine Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Inactivated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Inactivated Vaccine Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure China Inactivated Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Inactivated Vaccine Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Europe Inactivated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Inactivated Vaccine Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan Inactivated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Inactivated Vaccine Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Inactivated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Inactivated Vaccine Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure India Inactivated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Inactivated Vaccine Sales (K MT) Forecast by Type (2017-2022)
Figure Global Inactivated Vaccine Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Inactivated Vaccine Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Inactivated Vaccine Revenue Market Share Forecast by Type (2017-2022)
Table Global Inactivated Vaccine Price (USD/MT) Forecast by Type (2017-2022)
Table Global Inactivated Vaccine Sales (K MT) Forecast by Application (2017-2022)
Figure Global Inactivated Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories